Detalles de la búsqueda
1.
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
Radiology
; 307(4): e222010, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37070991
2.
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis.
Eur J Nucl Med Mol Imaging
; 48(4): 1200-1210, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970216
3.
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.
Eur J Nucl Med Mol Imaging
; 48(12): 4067-4076, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031719
4.
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Eur J Nucl Med Mol Imaging
; 48(1): 113-122, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383093
5.
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis.
Eur J Nucl Med Mol Imaging
; 47(9): 2106-2112, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062682
6.
Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells.
Transfus Med Hemother
; 44(3): 143-150, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28626365
7.
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.
Ann Nucl Med
; 36(3): 293-301, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854061
8.
Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management.
Cancers (Basel)
; 13(14)2021 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34298770
9.
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives.
Cancers (Basel)
; 13(15)2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359614
10.
Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapy.
Theranostics
; 11(17): 8143-8151, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373733
11.
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study.
Lancet Rheumatol
; 3(8): e563-e573, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287622
12.
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy.
Theranostics
; 10(17): 7645-7655, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32685010
13.
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy.
Theranostics
; 10(17): 7812-7820, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32685021
14.
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy.
J Nucl Med
; 61(5): 723-728, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601703
15.
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617.
Theranostics
; 9(17): 4841-4848, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410185
16.
Monocyte-Derived Interleukin-1ß As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Arthritis Rheumatol
; 71(5): 792-804, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447136
17.
S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.
Front Pediatr
; 6: 341, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30533405
Resultados
1 -
17
de 17
1
Próxima >
>>